EBAMed Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

EBAMed General Information

Description

Developer of the next-generation radiation therapy technology designed to treat cardiac arrhythmias from outside the heart. The company's device utilizes proton therapy, capable of selectively treating the tissues responsible for heart arrhythmias, enabling patients to undergo a non-invasive treatment in a single outpatient session.

Contact Information

Website
www.eba-med.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Chemin des Mines 15
  • 1202 Geneva
  • Switzerland
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • Chemin des Mines 15
  • 1202 Geneva
  • Switzerland

EBAMed Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EBAMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private 01-Feb-2026 Completed Generating Revenue
12. Later Stage VC (Series B) 23-Jun-2025 Completed Generating Revenue
11. Later Stage VC (Series A) 24-Jan-2025 Completed Generating Revenue
10. Grant 31-Aug-2023 Completed Generating Revenue
9. Early Stage VC 29-Jul-2021 Completed Generating Revenue
8. Grant 23-Sep-2020 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
6. Seed Round 21-Aug-2019 Completed Generating Revenue
5. Grant 23-Jul-2019 $56.4K $181K Completed Generating Revenue
4. Accelerator/Incubator 30-Oct-2018 $80.5K $181K Completed Generating Revenue
To view EBAMed’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

EBAMed Patents

EBAMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1152035-S1 Ultrasound probe assembly Active 27-Dec-2024
EP-4580508-A1 Ultrasound probe holding assembly Pending 29-Aug-2022
US-20260023048-A1 Ultrasound probe holding assembly Pending 29-Aug-2022
WO-2024062307-A1 Ultrasound probe holding assembly Inactive 29-Aug-2022
EP-4267243-A1 A multiplanar motion management system Pending 23-Dec-2020 A61N5/1068
To view EBAMed’s complete patent history, request access »

EBAMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EBAMed Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
EFI Lake Geneva Ventures Venture Capital Minority
European Union Government Minority
LIFTT Venture Capital Minority
OCCIDENT () Family Office Minority
Panakes Partners Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

EBAMed FAQs

  • When was EBAMed founded?

    EBAMed was founded in 2018.

  • Where is EBAMed headquartered?

    EBAMed is headquartered in Geneva, Switzerland.

  • What is the size of EBAMed?

    EBAMed has 18 total employees.

  • What industry is EBAMed in?

    EBAMed’s primary industry is Diagnostic Equipment.

  • Is EBAMed a private or public company?

    EBAMed is a Private company.

  • What is EBAMed’s current revenue?

    The current revenue for EBAMed is .

  • How much funding has EBAMed raised over time?

    EBAMed has raised $51.1M.

  • Who are EBAMed’s investors?

    EFI Lake Geneva Ventures, European Union, LIFTT, OCCIDENT (), and Panakes Partners are 5 of 10 investors who have invested in EBAMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process